News

Nicox Collaborates with Glaukos on Innovative NCX 1728'

Nicox Collaborates with Glaukos on Innovative NCX 1728'

Nicox Partners with Glaukos for NCX 1728 Research

Recently, Nicox SA, a global ophthalmology company, announced an exclusive partnership with Glaukos Corporation. This collaboration centers on the research and global licensing of NCX 1728, a groundbreaking compound aimed at treating serious eye conditions like glaucoma and various retinal diseases.

Highlights of the Agreement

The partnership grants Glaukos exclusive rights to license NCX 1728 on a global scale. This includes upfront payments along with milestone options and future royalties. The intention is to harness Glaukos’ expertise in treating eye disorders and their state-of-the-art drug delivery systems to refine NCX 1728 for a range of uses, such as lowering intraocular pressure and offering neuroprotection.

Research Activities Supported by Glaukos

According to the agreement, Glaukos will completely finance the preclinical research required to assess NCX 1728. This research aims to investigate the compound’s effectiveness in glaucoma treatment and its potential applications in retinal diseases. A Joint Steering Committee will oversee this joint research initiative.

Strategic Development Goals

In this strategic collaboration, Nicox will continue to focus on the advancement of its leading drug candidate, NCX 470, which is in Phase 3 development. NCX 470 is another NO-donating molecule designed to reduce intraocular pressure in patients with open-angle glaucoma and ocular hypertension.

More About NCX 1728

NCX 1728 is part of an innovative class of NO-donating phosphodiesterase-5 (PDE5) inhibitors. This special formulation is designed to enhance and extend the effects of nitric oxide (NO), which is crucial for treating various ocular conditions. By combining NO donation with PDE5 inhibition, it aims for better therapeutic results, especially in cases that require prolonged effects on reducing intraocular pressure.

About Nicox SA

Based in Sophia Antipolis, France, Nicox SA is committed to developing advanced solutions that enhance vision preservation and ocular health. Their product lineup includes revenue-generating items like VYZULTA®, which is licensed exclusively worldwide to Bausch + Lomb, and ZERVIATE®, which is licensed in several regions for treating allergic conjunctivitis.

Looking Ahead

This partnership between Nicox and Glaukos holds great promise not just for the companies involved but also for patients battling glaucoma and retinal diseases. With Glaukos taking the lead on preclinical research, both companies aim to unlock the full therapeutic potential of NCX 1728, paving the way for innovative treatments in the ophthalmic field.

Frequently Asked Questions

What is NCX 1728?

NCX 1728 is a new nitric oxide-donating phosphodiesterase-5 inhibitor designed for treating glaucoma and retinal diseases.

How does this partnership benefit patients?

This collaboration aims to create effective treatments that could significantly enhance patients' conditions related to intraocular pressure and neuroprotection.

What is Glaukos' role in this agreement?

Glaukos will fund and manage the preclinical research for NCX 1728 and has the option to license the compound for global development.

What is the current status of Nicox's development pipeline?

Nicox is currently focused on Phase 3 development of NCX 470, which is its lead candidate for open-angle glaucoma management.

Where can I find more information about Nicox?

You can find additional details about Nicox's products and developments on their official website.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

BETR's Legal Tangle: A Deeper Dive into Investor Turmoil

Updated Category News Views 157

BETR's Shaky Ground: When Promises Fall Short In the rough-and-tumble world of finance, there's little room for empty promises. Better Home & Finance Holding Company (NASDAQ: BETR) might have to learn that the hard way. Investors who snagged shares between March 13 and August 6, 2026, are now clutching their heads as they watch their investments nosedive. When companies...

Continue Reading
Sharon Stuart's Quest for Her Hidden Origins

Updated Category News Views 123

Delving Into Identity: A Personal Odyssey In a world where everyone seems to be searching for something, Sharon Stuart's quest is etched with the raw need to uncover her real origins. Abandoned as a newborn in the gritty streets of Oakland, she grew up grappling with looming questions about what made her who she is. Her journey is captured in her memoir, "Existing Without...

Continue Reading
Local Bounti Expands: Acquires CEA Facilities

Updated Category News Views 72

Local Bounti's Strategic Acquisition Move Local Bounti's at it again, shaking up the indoor agriculture scene by snapping up some real estate from Revol Greens. We're talking 30 acres of primo certified-organic greenhouse space across Texas and Minnesota. And they’re picking these babies up right as they’re ready to grow, not like some flashy land grab. Digging into...

Continue Reading
EUBG Faces Tough Third Quarter Amid Challenges

Updated Category News Views 187

What's Happening with EUBG? Entrepreneur Universe Bright Group, better known in the markets as EUBG, is navigating some choppy waters if their recent financial numbers are anything to go by. You'd think companies boasting a digital-focused strategy would be printing money in today's tech-driven world, but EUBG's third quarter of 2026 has a different story to tell. The...

Continue Reading
Quantum X and Everest Cloud Partner in South Asia Push

Updated Category News Views 87

An Unlikely Alliance for Cutting-Edge Tech You gotta admit, the fusion of a U.S.-based tech outfit with a Nepalese cloud provider wasn't the market move anyone saw coming. But here we are—Quantum X is hitching its quantum computing dreams to Everest Cloud's solid local foothold across six South Asian markets. We're talking Nepal, India, Bangladesh, Bhutan, Sri Lanka,...

Continue Reading
LinkedIn Shines: Brands Face Social Media Slump

Updated Category News Views 77

LinkedIn: The Unsung Hero in Social Platforms In a world where social media seems to be as unpredictable as the stock market, LinkedIn is surprisingly holding the line. According to Vista Social's 2027 report, LinkedIn proudly boasts the highest median engagement rate among brand pages at 5.8%. Now, in the wild west of social media, where reach is getting tougher to snag,...

Continue Reading
ISC2 Launches AI Security Academy for Cyber Pros

Updated Category News Views 194

AI-Driven Threats Demand Expert Attention Every corner of the tech world has been blabbering about AI, but when it comes to cybersecurity, it's a whole different beast entirely. ISC2—a nonprofit that I like to think of as the cyber wizards’ guild—just threw a lifeline to cybersecurity folks who are swimming in the deep end of AI. With their shiny new AI Security...

Continue Reading
Grupo Supervielle's Q3 2026: Back to Growth Path

Updated Category News Views 49

Mounting Momentum in Loans and Asset Quality Grupo Supervielle, the Argentine financial player, has been tinkering with its gears to navigate the bumpy roads of 2026. In the third quarter, the company reports a gentle uptick in net loans—up 1.3% sequentially. This was particularly felt in September, with loans increasing 3.7%. Holding Their Own Against the Industry...

Continue Reading
Epic Legal Battle Yields $63M Verdict Against Chevron

Updated Category News Views 359

A David vs. Goliath Showdown in Court How's this for a courtroom drama? Picture eight lawyers taking on Chevron over a toxic pit buried beneath an unsuspecting family's home. These folks at Ernst Law Group and Trial Lawyers for Justice tackled Union Oil (now Chevron) and bagged a staggering $63 million for their client. This ain't your run-of-the-mill legal squabble; it's...

Continue Reading
SahajMobile's $25M Boost: Impact on Bangladesh Market

Updated Category News Views 168

Untapped Digital Frontier in Bangladesh There's an undeniable buzz around SahajMobile's recent $25 million credit facility, and it's one worth dissecting. This shot of capital, lined up with ALMA as part of SahajMobile’s Series A gamble, is setting the stage for a real shuffle in Bangladesh's digital landscape. Plugging into a Market Gap Ever since it hit the ground...

Continue Reading

Top 5 Most Recently Viewed Articles

Navitas Semiconductor Stock Soars on Strong Q4 Performance

Updated Category News Views 257

Climbing Higher: NVTS Takes Off After Solid Earnings Out of nowhere, Navitas Semiconductor is buzzing with energy, and it’s no coincidence. After posting its fourth-quarter results, the stock skyrocketed—up over 25%. A quarterly loss of 5 cents per share? No biggie—it’s right where analysts expected. But that revenue? $7.30 million, cruising past the $6.95 million...

Continue Reading
Exploring the Expanding Sodium Sulfide Market with Insights

Updated Category News Views 126

Overview of the Global Sodium Sulfide Market The global sodium sulfide market is on a promising upward trajectory, with forecasts estimating its size to reach US$ 17.47 billion by 2034. This notable growth is expected to take place at a compound annual growth rate (CAGR) of 4.8% from 2024 through 2034, as outlined in a recent research study. Sodium sulfide finds extensive...

Continue Reading
Discover the Latest Innovations in Cordless Vacuum Technology

Updated Category News Views 207

Discover Tineco's New Cordless Vacuum Models Always innovating, Tineco has unveiled two remarkable cordless vacuum cleaners designed for modern living: the PURE ONE Station 5 and PURE ONE A50S. Both models combine state-of-the-art technology with practical features, making floor cleaning a breeze. With these intelligent vacuums, cleaning becomes a more pleasant...

Continue Reading
Carisma Therapeutics Initiates Voluntary Delisting from Nasdaq

Updated Category News Views 206

Carisma Therapeutics Unveils Delisting Plans from Nasdaq Carisma Therapeutics Inc. (OTCID: CARM) recently announced that its Board of Directors has approved a pivotal decision to voluntarily delist its common stock from The Nasdaq Stock Market LLC. This strategic move is aimed at deregistering the company’s common stock to suspend and ultimately conclude its reporting...

Continue Reading
Bragg's New Pineapple Turmeric Blend: A Refreshing Wellness Choice

Updated Category News Views 358

Bragg's Exciting New Product Launch A Tropical Twist on Bragg's Iconic ACV Hits Shelves Nationwide Introducing the Pineapple Turmeric ACV Blend Bragg Live Food Products, Inc. is making waves by expanding its product variety with a delightful new blend – the Pineapple Turmeric Apple Cider Vinegar (ACV) Blend. This innovative concoction signifies a fresh approach toward...

Continue Reading